Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

Y. Maehara, I. Takahashi, M. Yoshida, H. Baba, H. Kusumoto, H. Anai, K. Sugimachi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

Original languageEnglish
Pages (from-to)27-29
Number of pages3
JournalAnticancer Research
Volume13
Issue number1
Publication statusPublished - Jan 1 1993

Fingerprint

Stomach Neoplasms
Drug Therapy
Mitomycin
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Stomach
Survival Rate
Survival
Therapeutics
pyrimidine

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Maehara, Y., Takahashi, I., Yoshida, M., Baba, H., Kusumoto, H., Anai, H., & Sugimachi, K. (1993). Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65. Anticancer Research, 13(1), 27-29.

Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65. / Maehara, Y.; Takahashi, I.; Yoshida, M.; Baba, H.; Kusumoto, H.; Anai, H.; Sugimachi, K.

In: Anticancer Research, Vol. 13, No. 1, 01.01.1993, p. 27-29.

Research output: Contribution to journalArticle

Maehara, Y, Takahashi, I, Yoshida, M, Baba, H, Kusumoto, H, Anai, H & Sugimachi, K 1993, 'Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65', Anticancer Research, vol. 13, no. 1, pp. 27-29.
Maehara Y, Takahashi I, Yoshida M, Baba H, Kusumoto H, Anai H et al. Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65. Anticancer Research. 1993 Jan 1;13(1):27-29.
Maehara, Y. ; Takahashi, I. ; Yoshida, M. ; Baba, H. ; Kusumoto, H. ; Anai, H. ; Sugimachi, K. / Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65. In: Anticancer Research. 1993 ; Vol. 13, No. 1. pp. 27-29.
@article{4bf5807cd4e34e7f844d2c7a55f99927,
title = "Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65",
abstract = "We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.",
author = "Y. Maehara and I. Takahashi and M. Yoshida and H. Baba and H. Kusumoto and H. Anai and K. Sugimachi",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "13",
pages = "27--29",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

AU - Maehara, Y.

AU - Takahashi, I.

AU - Yoshida, M.

AU - Baba, H.

AU - Kusumoto, H.

AU - Anai, H.

AU - Sugimachi, K.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

AB - We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

UR - http://www.scopus.com/inward/record.url?scp=0027477514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027477514&partnerID=8YFLogxK

M3 - Article

C2 - 8476223

AN - SCOPUS:0027477514

VL - 13

SP - 27

EP - 29

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -